Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial

INTRODUCTION: The Strategic Timing of AntiRetroviral Treatment (START) trial has recruited antiretroviral-naïve individuals with high CD4 cell counts from all world regions. We describe the distribution of cardiovascular (CVD) risk factors, overall and by geographic region, at study baseline. METHOD...

Full description

Saved in:
Bibliographic Details
Published in:HIV Med
Main Authors: Soliman, Elsayed Z., Sharma, Shweta, Arastéh, Keikawus, Wohl, David, Achhra, Amit, Tambussi, Giuseppe, O’Connor, Jemma, Stein, James H., Duprez, Daniel A., Neaton, James D., Phillips, Andrew
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4341949/
https://ncbi.nlm.nih.gov/pubmed/25711323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12233
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items